WASHINGTON — GlaxoSmithKline PLC said Monday it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by ...
Read Whole Story
WASHINGTON — Federal health scientists have panned a GlaxoSmithKline study that the company used to defend the safety of its embattled diabetes ...
Get top stories and blogs posts emailed to you each day.